Associated Papers
Rare Germline Variants in CDKN2A-Negative Children and Adolescents With Cutaneous Melanoma.
Johansson PA et al.
Pigment Cell & Melanoma Research, 2026
41673532 (PubMed )
Supplement: PCMR-39-0-s001.xlsx › TableS3
High-throughput mapping of 6,888 RAD51D variants identifies distinct biochemical functions needed for homologous recombination and olaparib response.
Darrah KE et al.
Biorxiv : the Preprint Server for Biology, 2026
Genetic Features of Tumours Arising in the Context of Suspected Hereditary Cancer Syndromes with RAD50, RAD51C/D, and BRIP1 Germline Mutations, Results of NGS-Reanalysis of BRCA/MMR-Negative Families.
Arranz-Ledo M et al.
Genes, 2025
40282418 (PubMed )
Supplement: genes-16-00458-s001.zip › genes-3555243-supplementary.xlsx › Hoja2
Germline Variants in DNA Interstrand-Cross Link Repair Genes May Contribute to Increased Susceptibility for Serrated Polyposis Syndrome.
Silva P et al.
International Journal of Molecular Sciences, 2024
39519399 (PubMed )
Supplement: ijms-25-11848-s001.zip › ijms-3272320-supplementary.pdf
Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls.
Zanti M et al.
Frontiers in Genetics, 2023
37790698 (PubMed )
Supplement: DataSheet1.xlsx › Table_S2
TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing.
Lesueur F et al.
Cancers, 2021
34359559 (PubMed )
Supplement: cancers-13-03659-s001.zip › cancers-1273124-supplementary.pdf
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Bertucci F et al.
Genome Medicine, 2021
34006291 (PubMed )
Supplement: 13073_2021_897_MOESM3_ESM.xlsx › Table_S2
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
Song H et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2015
DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition.
Ollier M et al.
American Journal of Cancer Research, 2015
Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer.
Thompson ER et al.
Plos One, 2013
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families.
Osher DJ et al.
British Journal of Cancer, 2012
Select a paper to view details